Vertex Pharmaceuticals Inc (VRTX)
455.45
-4.61
(-1.00%)
USD |
NASDAQ |
Jun 13, 16:00
456.92
+1.47
(+0.32%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 116.96B for June 13, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen Inc | 158.74B |
| Gilead Sciences Inc | 136.81B |
| Eli Lilly and Co | 735.57B |
| Merck & Co Inc | 205.18B |
| Moderna Inc | 10.31B |
Market Cap Related Metrics
| PS Ratio | 10.63 |
| Price to Book Value | 7.09 |
| Price | 455.45 |
| Earnings Yield | -0.86% |
| Operating PE Ratio | 28.02 |
| Normalized PE Ratio | 40.00 |